Growth-Factor Signalling and Estrogen Receptor Coactivators during Endocrine Treatment of Breast Cancer
- Prosjektnummer
- 911652
- Ansvarlig person
- Marianne Hauglid Flågeng
- Institusjon
- Helse Bergen HF
- Prosjektkategori
- Forskerutdanning - postdoc
- Helsekategori
- Cancer
- Forskningsaktivitet
- 2. Aetiology
Inverse regulation of EGFR/HER1 and HER2-4 in normal and malignant human breast tissue.
PLoS One 2013;8(8):e74618. Epub 2013 aug 22
PMID: 23991224
Downregulation of steroid receptor coactivator-2 modulates estrogen-responsive genes and stimulates proliferation of mcf-7 breast cancer cells.
PLoS One 2013;8(7):e70096. Epub 2013 jul 30
PMID: 23936147
Steroid receptor coactivators, HER-2 and HER-3 expression is stimulated by tamoxifen treatment in DMBA-induced breast cancer.
BMC Cancer 2012;12():247. Epub 2012 jun 15
PMID: 22703232
Steroid receptor coactivators during short-term estrogen deprivation
Cold Spring Harbor Laboratory Meeting: Nuclear receptors and disease, 28.10.2014-01.11.2014
Inverse regulation of Neuregulin 1 and HER-3 during treatment with aromatase inhibitors of estrogen receptor positive BC
San Antonio Breast Cancer Symposium, 4.-8.12.2012.
Steroid reseptor koaktivatorer, HER-2 og hormonbehandling ved brystkreft
BestPractice
Characterization of Clobal Gene Expression in Breast Cancer Cells after cAMP/PKA-mediated downregulation of SRC-2
Nuclear receptors: From Molecular Mechanism to Health and Disease; 2011-09-16 - 2011-09-20
The nuclear receptor coactivator PELP1/MNAR is positively correlated with estrogen levels in breast cancer pat
Nuclear receptors - from molecular mechanisms to health and disease; 2011-09-16 - 2011-09-20
Steroid Receptor Coactivators and Endocrine Treatment in Breast Cancer
Nuclear Receptors. Nova Science Publishers, Inc. 2011 ISBN 978-1-61209-980-4. s. 35-66
Steroid Receptor Coactivators and Their Expression, Regulation and Functional Role in Endocrine Responsive and Resistant Breast
Breast Cancer - Carcinogenesis, Cell Growth and Signalling Pathways. INTECH 2011 ISBN 978-953-307-714-7. s. 715-732
Steroid receptor coactivators and epidermal growth factor receptors in breast cancer.
- Disputert:
- april 2011
- Hovedveileder:
- Mellgren Gunnar, Lien Ernst A
- Marianne Flågeng Postdoktor
- Per Eystein Lønning Medveileder
- Gunnar Mellgren Hovedveileder
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Faglig rapportering, Helse Vest